Flosequinan
Title: Flosequinan
CAS Registry Number: 76568-02-0
CAS Name: 7-Fluoro-1-methyl-3-(methylsulfinyl)-4(1H)-quinolinone
Additional Names: flosequinon
Manufacturers' Codes: BTS-49465
Trademarks: Manoplax (Boots)
Molecular Formula: C11H10FNO2S
Molecular Weight: 239.27
Percent Composition: C 55.22%, H 4.21%, F 7.94%, N 5.85%, O 13.37%, S 13.40%
Literature References: Mixed arterial and venous vasodilator. Prepn: R. V. Davies et al., DE 3011994; eidem, US 4302460 (1980, 1981 both to Boots). Pharmacology: J. G. Smith, G. T. Kinasewitz, J. Cardiovasc. Pharmacol. 8, 878 (1986); M. F. Sim et al., Br. J. Pharmacol. 94, 371 (1988). HPLC determn in plasma, serum and urine: M. B. Slegowski et al., J. Chromatogr. 425, 227 (1988). Pharmacokinetics and hemodynamics in humans: A. J. Cowley et al., J. Hypertens. 2, Suppl. 3, 547 (1984); R. D. Wynne et al., Eur. J. Clin. Pharmacol. 28, 659 (1985). Preliminary evaluation in hypertension: A. J. Cowley et al., ibid. 33, 203 (1987); in congestive heart failure: P. D. Kessler, M. Packer, Am. Heart J. 113, 137 (1987); P. D. Kessler et al., J. Cardiovasc. Pharmacol. 12, 6 (1988). Clinical study in chronic heart failure: A. J. Cowley et al., Br. Med. J. 297, 169 (1988).
Properties: Crystals, mp 226-228°.
Melting point: mp 226-228°
Therap-Cat: Antihypertensive.
Keywords: Antihypertensive.

Others monographs:
αMNPGlipizideα-LatrotoxinPifithrin-α
Chloric AcidHectoriteHydroxylamineTrichlorourethan
Vanadium TrioxideLipoprotein LipaseVirginiamycinSalinomycin
Lead SeleniteAluminum HexafluorosilicateAconitine, AmorphousAdlumidine
©2016 DrugLead US FDA&EMEA